[HTML][HTML] Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
J Liu, Y Chen, R Li, Z Wu, Q Xu, Z Li, D Annane… - Clinical Microbiology …, 2021 - Elsevier
Objectives Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …
although the clinical outcome of such treatment remains unclear. This study evaluated the …
[PDF][PDF] Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multi-center study
J Liu, Y Chen, R Li, X Dong, Y Li, Q Xu, H Feng… - scholar.archive.org
Background: Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-
19, although the clinical outcomes remain unclear. This study evaluated the effectiveness of …
19, although the clinical outcomes remain unclear. This study evaluated the effectiveness of …
Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
J Liu, Y Chen, R Li, Z Wu, Q Xu, Z Li… - Clinical Microbiology …, 2021 - hal.uvsq.fr
Objectives: Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …
although the clinical outcome of such treatment remains unclear. This study evaluated the …
[HTML][HTML] Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
J Liu, Y Chen, R Li, Z Wu, Q Xu… - Clinical …, 2021 - clinicalmicrobiologyandinfection …
Objectives Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …
although the clinical outcome of such treatment remains unclear. This study evaluated the …
[HTML][HTML] Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multi-center study
J Liu, Y Chen, R Li, X Dong, Y Li, Q Xu, H Feng… - 2020 - europepmc.org
Background: Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-
19, although the clinical outcomes remain unclear. This study evaluated the effectiveness of …
19, although the clinical outcomes remain unclear. This study evaluated the effectiveness of …
Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
J Liu, Y Chen, R Li, Z Wu, Q Xu, Z Li… - Clinical Microbiology …, 2021 - hal.science
Objectives: Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …
although the clinical outcome of such treatment remains unclear. This study evaluated the …
Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
J Liu, Y Chen, R Li, Z Wu, Q Xu, Z Li… - … and infection: the …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …
although the clinical outcome of such treatment remains unclear. This study evaluated the …
Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multi-center study
J Liu, Y Chen, R Li, X Dong, Y Li, Q Xu, H Feng… - 2020 - researchsquare.com
Background: Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-
19, although the clinical outcomes remain unclear. This study evaluated the effectiveness of …
19, although the clinical outcomes remain unclear. This study evaluated the effectiveness of …
[HTML][HTML] Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
J Liu, Y Chen, R Li, Z Wu, Q Xu, Z Li… - Clinical Microbiology …, 2021 - ncbi.nlm.nih.gov
Objectives Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …
although the clinical outcome of such treatment remains unclear. This study evaluated the …
Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study.
J Liu, Y Chen, R Li, Z Wu, Q Xu, Z Li, D Annane… - 2021 - cabidigitallibrary.org
Objectives: Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …
although the clinical outcome of such treatment remains unclear. This study evaluated the …